Latarjet Procedure for the Treatment of Anterior Glenohumeral Instability in the Athlete - Key Considerations for Rehabilitation.
Helen Bradley, Lucca Lacheta, Brandon T Goldenberg and 3 others
PMID 33604154WHAT IT FOUND
This is a proposed five-phase rehab protocol for athletes after Latarjet shoulder surgery, moving from protection to power.
It relies on expert opinion and clinical experience, not trial data, so it offers a framework to discuss with your surgeon rather than proven outcomes.
Key findings
01The paper presents a clinical commentary describing a rehabilitation protocol, not a study with results.
02The proposed progression moves through five phases: Protection, Endurance, Strength, Power, and Return to Play.
03The authors state that evidence supporting specific rehabilitation protocols for this surgery is limited.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is an expert opinion piece, not a clinical trial. The proposed protocol has not been tested for efficacy or safety in a controlled study. The authors acknowledge that literature supporting specific rehabilitation protocols for Latarjet reconstruction is limited. Progression criteria are based on clinical experience and general sports medicine principles rather than Latarjet-specific validation. The protocol is designed for athletes, which may not apply to non-athletic populations with different functional goals.
Declared interests
The authors declare no conflicts of interest. The paper does not report external funding.
The easy way to misread this
Do not treat this protocol as evidence-based standard of care. The authors state that evidence for specific rehabilitation protocols after Latarjet surgery is limited, and this algorithm is based on their clinical expertise. Implementing these specific timelines or load targets without surgeon approval could risk graft failure or other complications.